Home infusion nurses regularly administer medications carrying FDA black box warnings, the agency’s most serious safety designation, yet many organizations lack a structured, end-to-end approach to preparing staff for these therapies. This session brings together three perspectives, pharmacy, clinical nursing, and leadership, to give attendees a complete picture of how to safely manage black box warning drugs in the home setting. Attendees will leave with a clear understanding of what these warnings mean clinically, how nurses should prepare for and conduct visits involving these medications, how to recognize and respond to adverse reactions, and how organizational leadership can build systems that protect both patients and staff.
Describe how nurses should prepare for, monitor during, and respond to adverse reactions during visits involving black box warning drugs.
Identify organizational strategies leadership can use to maintain safety, quality, and service consistency when black box warning drugs are part of routine care.
